Skip to content
ScienceBlog.com
  • Featured Blogs
    • EU Horizon Blog
    • ESA Tracker
    • Experimental Frontiers
    • Josh Mitteldorf’s Aging Matters
    • Dr. Lu Zhang’s Gondwanaland
    • NeuroEdge
    • NIAAA
    • SciChi
    • The Poetry of Science
    • Wild Science
  • Topics
    • Brain & Behavior
    • Earth, Energy & Environment
    • Health
    • Life & Non-humans
    • Physics & Mathematics
    • Social Sciences
    • Space
    • Technology
  • Our Substack
  • Follow Us!
    • Bluesky
    • Threads
    • FaceBook
    • Google News
    • Twitter/X
  • Contribute/Contact

Harvard University

Young man watching tv in the dark

The rise of ‘incels’

Ground beef

Red meat consumption associated with increased type 2 diabetes risk

Heart illustration

Heart cells start beating suddenly and all at once

Illustration of a heart and stethoscope

Transfer of ageing: New drug class prevents key ageing mechanism in organ transplants

Researchers create ‘designer bacteria’ to target autoimmunity in the brain, making treatment safer and more effective

Engineered probiotic developed to treat multiple sclerosis

Neurons. Alzheimer’s disease varies widely in its age of onset, presentation, and severity. Recently, the SORL1 gene has received increased attention since variations in this gene have been associated with both early- and late-onset Alzheimer’s. However, little is known about how damage to SORL1 leads to disease. Using stem cells from patients with Alzheimer’s, investigators from Harvard-affiliated Brigham and Women’s Hospital found that loss of normal SORL1 function leads to a reduction in two key proteins known to be involved in Alzheimer’s and which play an essential role in the neurons of healthy individuals. Their results, published in Cell Reports, suggest a potential strategy for Alzheimer’s disease treatment, especially for patients not responsive to existing therapies. In this new study, the researchers utilized a stem-cell based approach that examined natural genetic variability in Alzheimer’s patients to gain insight into an alternative pathway driving disease. The researchers used CRISPR technologies to remove the SORL1 gene from progenitor stem cells, derived from participants in two Alzheimer’s research cohorts, the Religious Order Studies and Rush Memory and Aging Project. They then programmed the stem cells to differentiate into four different kinds of brain cells to examine the impact of removing SORL1 on each cell type. The most dramatic impact was seen in neurons and a “support” cell in the brain (astrocytes). Neurons lacking SORL1 demonstrated especially prominent reduction in the levels of two key Alzheimer’s disease proteins: APOE and CLU. Without APOE and CLU, neurons cannot properly regulate lipids, which accumulate in droplets that may impair neurons’ abilities to communicate with each other. The researchers verified their lab-based results by examining natural genetic variation in SORL1 expression in the brain tissue of 50 members of the cohorts, finding again that lower SORL1 activity in neurons was correlated with reduced APOE and CLU in these people. Historically, researchers have studied three potent genetic drivers of Alzheimer’s disease (APP, PSEN1 and PSEN2), which are commonly mutated in hereditary, early-onset Alzheimer’s (AD diagnosis before age 65). Preclinical models and cell-based systems largely rely on mutations in these genes to model Alzheimer’s disease, even though in many people with late-onset (“sporadic”) Alzheimer’s, a more complex interaction between genes, lifestyle, and environment determines the presentation of the disease. Key neurological features of Alzheimer’s disease, including the abundance of amyloid-beta plaques in the brain, also vary across individuals. “Our study is one of the first with human cells from a large collection of individuals to try to understand the ‘molecular road’ that starts with SORL1, which we now see converges with APOE,” said corresponding author Tracy Young-Pearse of the Ann Romney Center for Neurological Diseases. “Our research points to the importance of developing interventions that target these and other molecular roads to Alzheimer’s disease. The more we can understand subtype-specific differences in AD, the better we will be able to design rational therapeutic interventions to try to fix the problem that is primarily driving disease in each patient.” The researchers are continuing to study other pathways that may lead to Alzheimer’s disease, such as those involving microglia (brain cells that perform immune functions). By using study models and techniques reflective of Alzheimer’s disease presentation in the general population, the researchers hope to identify additional biological pathways important in Alzheimer’s disease. In addition, Brigham researchers have played a leadership role in understanding the molecular and genetic basis for Alzheimer’s disease, including making key discoveries related to the amyloid protein. Two novel anti-amyloid therapies, aducanumab and lecanemab, have received U.S. Food and Drug Administration accelerated and traditional approval, respectively, but not all patients respond to these drugs, warranting other treatment options. This work was supported by the National Institutes of Health (F31AG063399, U01AG072572, U01AG061356, RF1NS117446 and R01AG055909).

The road that ends with Alzheimer’s

Chemical analysis brings understudied microbiome into sharper focus

Vaginal bacteria must eat to survive — but how?

Snarling do. From Harvard PIO

As temps climb so do number of dog bites

Omega 3 molecules

Omega-3 Fatty Acids May Slow ALS Progression, Reduce Death Risk

Rose colored glasses

Moral breakdown is a fake problem

Back massage near hip. Credit Pixabay

Projected Increase in Hip Fracture Burden Calls for Urgent Prevention and Care Strategies

Where the 2020 fires contributed the most to smoke exposure over the western US. Red indicates the areas with the most smoke impact in September 2020, averaged over the western US and weighted for population. Blue indicates fires with the least smoke impact.

How prescribed burns could limit megafires in California, Oregon, and Washington

Woman's hand holding a red apple

Flavonol-rich foods like apples and blackberries can lower chances of developing frailty

Marking his 55th year at Harvard, Professor Richard Losick received the first Microbial Sciences Initiative’s Distinguished Achievement Award. In his award address, he shared the real story of DNA’s discovery. Stephanie Mitchell/Harvard Staff Photographer

How greatest biological discovery of 20th century got passed over

Older posts
Newer posts
← Previous Page1 … Page4 Page5 Page6 … Page20 Next →
Substack subscription form sign up

Comments

  • Mark Mellinger on Living Plastic Can Self-Destruct on Command
  • Marie Feret on The Silent Frequency That Makes Old Buildings Feel Haunted
  • Dax on The Silent Frequency That Makes Old Buildings Feel Haunted
  • Karoly Mirnics on Common Prescription Drugs May Disrupt Cholesterol Pathways in the Womb and Raise Autism Risk
  • Aizen on Laziness helped lead to extinction of Homo erectus
© 2026 ScienceBlog.com | Follow our RSS / XML feed